intervene in a prospective fashion. In this study, we sought to measure the impact of nonadherence to NCCN Guidelines on survival and disease recurrence in patients with HNSCC at a large urban health center, and investigated risk factors predictive of delay
Search Results
Impact of Nonadherence to NCCN Adjuvant Radiotherapy Initiation Guidelines in Head and Neck Squamous Cell Carcinoma in an Underserved Urban Population
Anusha Ponduri, David Z. Liao, Nicolas F. Schlecht, Gregory Rosenblatt, Michael B. Prystowsky, Rafi Kabarriti, Madhur Garg, Thomas J. Ow, Bradley A. Schiff, Richard V. Smith, and Vikas Mehta
Efficacy and Toxicity Analysis of Capecitabine and Temozolomide in Neuroendocrine Neoplasms
Taymeyah Al-Toubah, Eleonora Pelle, Tiffany Valone, Mintallah Haider, and Jonathan R. Strosberg
gastrointestinal NETs. Although moderately powered studies are sufficient to determine critical outcomes such as ORR and PFS, larger databases are key to answering other important questions. These include the frequency of rare toxicities, risk factors for
Complications of Multiple Myeloma Therapy, Part 1: Risk Reduction and Management of Peripheral Neuropathy and Asthenia
Paul G. Richardson, Jacob P. Laubach, Robert L. Schlossman, Constantine Mitsiades, and Kenneth Anderson
neuropathy may be detected in 11% to 52% and 39% to 46% of these populations, respectively. 1 – 6 Risk factors for PN include treatment-specific characteristics, such as therapy duration, dose intensity, and cumulative dose, and patient-specific factors
Risk Stratification and Emerging Treatment Strategies in Acute Myeloid Leukemia
Margaret R. O’Donnell
“In the majority of our patients, the major risk factor for whether they will do well or poorly is related to their cytogenetic and/or molecular markers,” stated Margaret R. O’Donnell, MD, Associate Clinical Director, Division of Hematology and
Health Behaviors and Quality of Life Among Colorectal Cancer Survivors
Elizabeth A. Rohan, Julie S. Townsend, Temeika L. Fairley, and Sherri L. Stewart
addressed in interventions. Methods Behavioral Risk Factor Surveillance System Survey This study used the Behavioral Risk Factor Surveillance System (BRFSS), a state-based system of health surveys that collects information on health risk
Alcohol Use Among Patients With Cancer and Survivors in the United States, 2000–2017
Nina N. Sanford, David J. Sher, Xiaohan Xu, Chul Ahn, Anthony V. D’Amico, Ayal A. Aizer, and Brandon A. Mahal
Background Alcohol use has been identified as a risk factor for several malignancies, including cancers of the head and neck, esophagus, colorectum, liver, and breast. 1 – 3 Epidemiologic studies have shown that higher alcohol consumption over
Role of Surgery for Locally Advanced and Metastatic Renal Cell Carcinoma
Robert Torrey, Philippe E. Spiess, Sumanta K. Pal, and David Josephson
study from MD Anderson Cancer Center, adverse risk factors were described as positive local recurrence margin, increased size of recurrence, presence of sarcomatoid features, and abnormal serum alkaline phosphatase or lactate dehydrogenase. Patients with
Radiation Therapy and Breast Cancer Risk
Andrea K. Ng and Lois B. Travis
.9%. 61 Although these excesses are largely related to preexisting breast cancer risk factors, prior radiation therapy, especially treatment at a young age, may contribute to the increased risk. 28 - 30 , 62 In early case-control studies by Storm et al
Pancreatic Adenocarcinoma
Margaret A. Tempero, J. Pablo Arnoletti, Stephen Behrman, Edgar Ben-Josef, Al B. Benson III, Jordan D. Berlin, John L. Cameron, Ephraim S. Casper, Steven J. Cohen, Michelle Duff, Joshua D.I. Ellenhorn, William G. Hawkins, John P. Hoffman, Boris W. Kuvshinoff II, Mokenge P. Malafa, Peter Muscarella II, Eric K. Nakakura, Aaron R. Sasson, Sarah P. Thayer, Douglas S. Tyler, Robert S. Warren, Samuel Whiting, Christopher Willett, and Robert A. Wolff
unanimously endorses participation in a clinical trial as the preferred option over standard or accepted therapy. Risk Factors and Genetic Predisposition Although the associated increase in risk is small, the development of pancreatic cancer is firmly
Cardiovascular Health and Risk Management in Cancer Survivors
Presented by: Javid J. Moslehi
-oncology. “Common risk factors predispose people to both cardiovascular disease and cancer. This has major implications for patients about to undergo systemic cancer treatment and also implications for survivorship,” he told the audience at the NCCN 2020 Virtual
